Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-15-000548
Filing Date
2015-12-21
Accepted
2015-12-21 15:30:27
Documents
44
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 10-31-2015 form_10-q.htm 10-Q 231322
2 SUBSIDIARIES OF THE REGISTRANT ex_21.htm EX-21 841
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5992
4 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3667
  Complete submission text file 0001161697-15-000548.txt   1538173

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ntrr-20151031.xml EX-101.INS 217493
6 XBRL SCHEMA FILE ntrr-20151031.xsd EX-101.SCH 20660
7 XBRL CALCULATION FILE ntrr-20151031_cal.xml EX-101.CAL 25552
8 XBRL DEFINITION FILE ntrr-20151031_def.xml EX-101.DEF 86173
9 XBRL LABEL FILE ntrr-20151031_lab.xml EX-101.LAB 137242
10 XBRL PRESENTATION FILE ntrr-20151031_pre.xml EX-101.PRE 124696
Mailing Address 400 SOUTH 4TH STREET SUITE 500 LAS VEGAS NV 89101
Business Address 400 SOUTH 4TH STREET SUITE 500 LAS VEGAS NV 89101 (702) 793-4121
NEUTRA CORP. (Filer) CIK: 0001512886 (see all company filings)

EIN.: 274505461 | State of Incorp.: FL | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 000-55077 | Film No.: 151299377
SIC: 2833 Medicinal Chemicals & Botanical Products